Clinical Trial Update: Continued Access to RXDX-105 [Phase 1]

View source ↗

Summary

This clinical trial update concerns continued access to RXDX-105 in a Phase 1 study for non-small cell lung cancer and ovarian cancer, including patients with R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Ovarian Cancer

Drugs mentioned

• RXDX-105

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Non Small Cell Lung Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED